{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:42:39Z","timestamp":1789951359030,"version":"4.0.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.2215\/cjn.14021118","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T15:54:25Z","timestamp":1551282865000},"page":"617-619","source":"Crossref","is-referenced-by-count":63,"title":["Stopping RAS Inhibitors to Minimize AKI"],"prefix":"10.2215","volume":"14","author":[{"given":"Charles","family":"Tomson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"B1-20230601","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2215\/CJN.03470316","article-title":"Incidence, severity, and outcomes of AKI associated with dual renin-angiotensin system blockade","volume":"11","author":"Palevsky","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2-20230601","doi-asserted-by":"crossref","first-page":"e012674","DOI":"10.1136\/bmjopen-2016-012674","article-title":"What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis","volume":"7","author":"Whiting","year":"2017","journal-title":"BMJ Open"},{"key":"B3-20230601","doi-asserted-by":"crossref","first-page":"e012690","DOI":"10.1136\/bmjopen-2016-012690","article-title":"Prescription of renin-angiotensin system blockers and risk of acute kidney injury: A population-based cohort study","volume":"6","author":"Mansfield","year":"2016","journal-title":"BMJ Open"},{"key":"B4-20230601","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2147\/CLEP.S146757","article-title":"Acute kidney injury and infections in patients taking antihypertensive drugs: A self-controlled case series analysis","volume":"10","author":"Mansfield","year":"2018","journal-title":"Clin Epidemiol"},{"key":"B5-20230601","doi-asserted-by":"crossref","first-page":"384","DOI":"10.7861\/clinmedicine.18-5-384","article-title":"Acute kidney injury and \u2018nephrotoxins\u2019: Mind your language","volume":"18","author":"Jones","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"B6-20230601","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2215\/CJN.12591117","article-title":"Acute kidney injury and risk of heart failure and atherosclerotic events","volume":"13","author":"Go","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7-20230601","article-title":"Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury [published online ahead of print May 15, 2018]","author":"Gayat","journal-title":"Intensive Care Med"},{"key":"B8-20230601","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jamainternmed.2018.4749","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with outcomes after acute kidney injury","volume":"178","author":"Brar","year":"2018","journal-title":"JAMA Intern Med"},{"key":"B9-20230601","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrneph.2013.80","article-title":"Three feasible strategies to minimize kidney injury in \u2018incipient AKI\u2019","volume":"9","author":"Perazella","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B10-20230601","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2018-314158","article-title":"Change in renal function associated with drug treatment in heart failure: national guidance","author":"Clark","year":"2019","journal-title":"Heart"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201904000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:35Z","timestamp":1786369235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201904000-00023"}},"subtitle":["More Harm than Good?"],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.14021118","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]}}}